In the last 12 months, insiders at Avidity Biosciences, Inc. ($RNAM) filed 506 transactions with the SEC: 0 open-market purchases totaling $0 and 146 sales totaling $102,083,349. Net insider sentiment: net selling.
Avidity Biosciences, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Boyce Sarah (President and CEO) — 80 transactions totaling $34,016,902
- MacLean Michael F (Chief Financial Officer) — 45 transactions totaling $17,727,981
- Flanagan W. Michael (CSTO) — 25 transactions totaling $14,933,926
- LEVIN ARTHUR A (Director) — 49 transactions totaling $14,390,069
- McCarthy Teresa (Chief Human Resources Officer) — 52 transactions totaling $11,873,670
View all SEC Filings for Avidity Biosciences, Inc. (RNAM).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Hughes Steven George | Chief Medical Officer | D | Stock Option (Right to Buy) | 74000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.05% |
| Feb. 27, 2026 | Henig Noreen | Not found | D | Stock Option (Right to Buy) | 10034 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Henig Noreen | Not found | D | Common Stock | 6692 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.00% |
| Feb. 27, 2026 | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 16000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 13520 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 42480 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 27584 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.02% |
| Feb. 27, 2026 | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 13352 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 9244 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 13829 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 22321 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Gallagher Kathleen P. | Chief Program Officer | D | Common Stock | 80303 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.05% |
| Feb. 27, 2026 | WILSON TROY EDWARD | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | WILSON TROY EDWARD | Not found | D | Stock Option (Right to Buy) | 13489 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | WILSON TROY EDWARD | Not found | D | Stock Option (Right to Buy) | 10034 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | WILSON TROY EDWARD | Not found | D | Common Stock | 13711 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | WILSON TROY EDWARD | Not found | D | Common Stock | 65091 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.04% |
| Feb. 27, 2026 | Flanagan W. Michael | Chief Scientific Officer | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Flanagan W. Michael | Chief Scientific Officer | D | Stock Option (Right to Buy) | 88000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.06% |
| Feb. 27, 2026 | Flanagan W. Michael | Chief Scientific Officer | D | Stock Option (Right to Buy) | 72000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.05% |
| Feb. 27, 2026 | Flanagan W. Michael | Chief Scientific Officer | D | Stock Option (Right to Buy) | 96000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.06% |
| Feb. 27, 2026 | Flanagan W. Michael | Chief Scientific Officer | D | Stock Option (Right to Buy) | 66500 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.04% |
| Feb. 27, 2026 | Flanagan W. Michael | Chief Scientific Officer | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.02% |
| Feb. 27, 2026 | Flanagan W. Michael | Chief Scientific Officer | D | Common Stock | 150365 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.10% |
| Feb. 27, 2026 | Moriarty John B | Chief Legal Officer | D | Stock Option (Right to Buy) | 160000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.11% |
| Feb. 27, 2026 | Moriarty John B | Chief Legal Officer | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Moriarty John B | Chief Legal Officer | D | Common Stock | 92054 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.06% |
| Feb. 27, 2026 | Boyce Sarah | President and CEO | D | Stock Option (Right to Buy) | 165000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.11% |
| Feb. 27, 2026 | Boyce Sarah | President and CEO | D | Stock Option (Right to Buy) | 300000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.20% |
| Feb. 27, 2026 | Boyce Sarah | President and CEO | D | Stock Option (Right to Buy) | 200000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.13% |
| Feb. 27, 2026 | Boyce Sarah | President and CEO | D | Stock Option (Right to Buy) | 400000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.27% |
| Feb. 27, 2026 | Boyce Sarah | President and CEO | D | Stock Option (Right to Buy) | 425000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.28% |
| Feb. 27, 2026 | Boyce Sarah | President and CEO | D | Stock Option (Right to Buy) | 300000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.20% |
| Feb. 27, 2026 | Boyce Sarah | President and CEO | D | Stock Option (Right to Buy) | 386015 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.26% |
| Feb. 27, 2026 | Boyce Sarah | President and CEO | D | Common Stock | 474861 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.32% |
| Feb. 27, 2026 | Hughes Steven George | Chief Medical Officer | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Hughes Steven George | Chief Medical Officer | D | Stock Option (Right to Buy) | 68458 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.05% |
| Feb. 27, 2026 | Hughes Steven George | Chief Medical Officer | D | Stock Option (Right to Buy) | 49333 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Hughes Steven George | Chief Medical Officer | D | Stock Option (Right to Buy) | 73342 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.05% |
| Feb. 27, 2026 | McCarthy Teresa | Chief Human Resources Officer | D | Common Stock | 165296 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.11% |
| Feb. 27, 2026 | McCarthy Teresa | Chief Human Resources Officer | D | Stock Option (Right to Buy) | 106000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.07% |
| Feb. 27, 2026 | McCarthy Teresa | Chief Human Resources Officer | D | Stock Option (Right to Buy) | 65000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.04% |
| Feb. 27, 2026 | McCarthy Teresa | Chief Human Resources Officer | D | Stock Option (Right to Buy) | 57500 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.04% |
| Feb. 27, 2026 | McCarthy Teresa | Chief Human Resources Officer | D | Stock Option (Right to Buy) | 108000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.07% |
| Feb. 27, 2026 | McCarthy Teresa | Chief Human Resources Officer | D | Stock Option (Right to Buy) | 54000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.04% |
| Feb. 27, 2026 | McCarthy Teresa | Chief Human Resources Officer | D | Stock Option (Right to Buy) | 78000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.05% |
| Feb. 27, 2026 | McCarthy Teresa | Chief Human Resources Officer | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Thompson Tamar | Not found | D | Common Stock | 6692 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.00% |
| Feb. 27, 2026 | Thompson Tamar | Not found | D | Stock Option (Right to Buy) | 10034 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Thompson Tamar | Not found | D | Stock Option (Right to Buy) | 13489 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Thompson Tamar | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Thompson Tamar | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | MacLean Michael F | Chief Financial Officer | D | Common Stock | 133977 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.09% |
| Feb. 27, 2026 | MacLean Michael F | Chief Financial Officer | D | Stock Option (Right to Buy) | 92000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.06% |
| Feb. 27, 2026 | MacLean Michael F | Chief Financial Officer | D | Stock Option (Right to Buy) | 131250 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.09% |
| Feb. 27, 2026 | MacLean Michael F | Chief Financial Officer | D | Stock Option (Right to Buy) | 148000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.10% |
| Feb. 27, 2026 | MacLean Michael F | Chief Financial Officer | D | Stock Option (Right to Buy) | 60125 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.04% |
| Feb. 27, 2026 | MacLean Michael F | Chief Financial Officer | D | Stock Option (Right to Buy) | 106000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.07% |
| Feb. 27, 2026 | MacLean Michael F | Chief Financial Officer | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Skerjanec Simona | Not found | D | Common Stock | 6692 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.00% |
| Feb. 27, 2026 | Skerjanec Simona | Not found | D | Stock Option (Right to Buy) | 10034 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Skerjanec Simona | Not found | D | Stock Option (Right to Buy) | 42308 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Hughes Steven George | Chief Medical Officer | D | Common Stock | 115857 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.08% |
| Feb. 27, 2026 | Calderaro Charles III | Chief Technical Officer | D | Stock Option (Right to Buy) | 80000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.05% |
| Feb. 27, 2026 | Calderaro Charles III | Chief Technical Officer | D | Common Stock | 98547 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.07% |
| Feb. 27, 2026 | Mosbrooker Eric | Chief Commercial Officer | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Mosbrooker Eric | Chief Commercial Officer | D | Stock Option (Right to Buy) | 177188 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.12% |
| Feb. 27, 2026 | Mosbrooker Eric | Chief Commercial Officer | D | Common Stock | 79413 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.05% |
| Feb. 27, 2026 | BOESS CARSTEN | Not found | D | Stock Option (Right to Buy) | 20858 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | BOESS CARSTEN | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | BOESS CARSTEN | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | BOESS CARSTEN | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | BOESS CARSTEN | Not found | D | Stock Option (Right to Buy) | 13489 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | BOESS CARSTEN | Not found | D | Stock Option (Right to Buy) | 10034 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | BOESS CARSTEN | Not found | D | Common Stock | 6692 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.00% |
| Feb. 27, 2026 | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 9534 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 11323 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 13489 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 10034 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Kaye Edward M. MD | Not found | D | Common Stock | 6692 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.00% |
| Feb. 27, 2026 | LEVIN ARTHUR A | Not found | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | LEVIN ARTHUR A | Not found | D | Stock Option (Right to Buy) | 115500 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.08% |
| Feb. 27, 2026 | LEVIN ARTHUR A | Not found | D | Stock Option (Right to Buy) | 144000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.10% |
| Feb. 27, 2026 | LEVIN ARTHUR A | Not found | D | Stock Option (Right to Buy) | 13489 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | LEVIN ARTHUR A | Not found | D | Stock Option (Right to Buy) | 10034 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | LEVIN ARTHUR A | Not found | D | Common Stock | 131372 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.09% |
| Feb. 27, 2026 | LEVIN ARTHUR A | Not found | D | Common Stock | 16562 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Kim Jean Jinsun | Not found | D | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.02% |
| Feb. 27, 2026 | Kim Jean Jinsun | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Kim Jean Jinsun | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Kim Jean Jinsun | Not found | D | Stock Option (Right to Buy) | 13489 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Kim Jean Jinsun | Not found | D | Stock Option (Right to Buy) | 10034 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Kim Jean Jinsun | Not found | D | Common Stock | 6692 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.00% |
| Feb. 27, 2026 | Henig Noreen | Not found | D | Stock Option (Right to Buy) | 9534 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Henig Noreen | Not found | D | Stock Option (Right to Buy) | 11323 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Henig Noreen | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Henig Noreen | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Henig Noreen | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Henig Noreen | Not found | D | Stock Option (Right to Buy) | 13489 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Jan. 21, 2026 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 1476 | $72.45 | 115,391.0000 | 150,675,742 | 1.26% | 0.00% |
| Jan. 21, 2026 | Boyce Sarah | President and CEO | S | Common Stock | 6394 | $72.45 | 277,000.0000 | 150,675,742 | 2.26% | 0.00% |
| Jan. 21, 2026 | Boyce Sarah | President and CEO | S | Common Stock | 7993 | $72.45 | 269,007.0000 | 150,675,742 | 2.89% | 0.01% |
| Jan. 21, 2026 | Flanagan W. Michael | Chief Scientific Officer | S | Common Stock | 3976 | $72.45 | 87,651.0000 | 150,675,742 | 4.34% | 0.00% |
| Jan. 21, 2026 | Flanagan W. Michael | Chief Scientific Officer | S | Common Stock | 2558 | $72.45 | 85,093.0000 | 150,675,742 | 2.92% | 0.00% |
| Jan. 21, 2026 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 1807 | $72.45 | 62,025.0000 | 150,675,742 | 2.83% | 0.00% |
| Jan. 21, 2026 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 2735 | $72.45 | 59,290.0000 | 150,675,742 | 4.41% | 0.00% |
| Jan. 21, 2026 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 1453 | $72.45 | 113,938.0000 | 150,675,742 | 1.26% | 0.00% |
| Jan. 21, 2026 | LEVIN ARTHUR A | Director | S | Common Stock | 1758 | $72.45 | 170,434.0000 | 150,675,742 | 1.02% | 0.00% |
| Jan. 21, 2026 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 2017 | $72.45 | 34,477.0000 | 150,675,742 | 5.53% | 0.00% |
| Jan. 21, 2026 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 2878 | $72.45 | 31,599.0000 | 150,675,742 | 8.35% | 0.00% |
| Jan. 7, 2026 | Flanagan W. Michael | Chief Scientific Officer | S | Common Stock | 2373 | $72.23 | 91,627.0000 | 150,675,742 | 2.52% | 0.00% |
| Jan. 7, 2026 | Boyce Sarah | President and CEO | S | Common Stock | 8576 | $72.23 | 283,394.0000 | 150,675,742 | 2.94% | 0.01% |
| Jan. 7, 2026 | Calderaro Charles III | Chief Technical Officer | S | Common Stock | 3727 | $72.23 | 49,797.0000 | 150,675,742 | 6.96% | 0.00% |
| Jan. 7, 2026 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 1965 | $72.23 | 116,867.0000 | 150,675,742 | 1.65% | 0.00% |
| Jan. 7, 2026 | Moriarty John B | Chief Legal Officer | S | Common Stock | 2374 | $72.23 | 74,557.0000 | 150,675,742 | 3.09% | 0.00% |
| Jan. 7, 2026 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 1974 | $72.23 | 63,832.0000 | 150,675,742 | 3.00% | 0.00% |
| Jan. 7, 2026 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 2373 | $72.23 | 36,494.0000 | 150,675,742 | 6.11% | 0.00% |
| Dec. 19, 2025 | LEVIN ARTHUR A | Director | G | Common Stock | 1330 | $0.00 | 172,192.0000 | 150,675,742 | 0.77% | 0.00% |
| Dec. 17, 2025 | McCarthy Teresa | Chief Human Resources Officer | F | Common Stock | 17298 | $71.87 | 118,832.0000 | 150,675,742 | 12.71% | 0.01% |
| Dec. 17, 2025 | Calderaro Charles III | Chief Technical Officer | A | Common Stock | 23250 | $0.00 | 63,250.0000 | 150,675,742 | 58.13% | 0.02% |
| Dec. 17, 2025 | Calderaro Charles III | Chief Technical Officer | F | Common Stock | 9726 | $71.87 | 53,524.0000 | 150,675,742 | 15.38% | 0.01% |
| Dec. 17, 2025 | Flanagan W. Michael | Chief Scientific Officer | A | Common Stock | 27500 | $0.00 | 107,695.0000 | 150,675,742 | 34.29% | 0.02% |
| Dec. 17, 2025 | Flanagan W. Michael | Chief Scientific Officer | F | Common Stock | 13695 | $71.87 | 94,000.0000 | 150,675,742 | 12.72% | 0.01% |
| Dec. 17, 2025 | Mosbrooker Eric | Chief Commercial Officer | A | Common Stock | 72000 | $0.00 | 127,000.0000 | 150,675,742 | 130.91% | 0.05% |
| Dec. 17, 2025 | Mosbrooker Eric | Chief Commercial Officer | F | Common Stock | 36564 | $71.87 | 90,436.0000 | 150,675,742 | 28.79% | 0.02% |
| Dec. 17, 2025 | Mosbrooker Eric | Chief Commercial Officer | F | Common Stock | 11426 | $71.87 | 79,010.0000 | 150,675,742 | 12.63% | 0.01% |
| Dec. 17, 2025 | Boyce Sarah | President and CEO | A | Common Stock | 31000 | $0.00 | 336,871.0000 | 150,675,742 | 10.13% | 0.02% |
| Dec. 17, 2025 | Boyce Sarah | President and CEO | F | Common Stock | 15742 | $71.87 | 321,129.0000 | 150,675,742 | 4.67% | 0.01% |
| Dec. 18, 2025 | Boyce Sarah | President and CEO | G | Common Stock | 29159 | $0.00 | 291,970.0000 | 150,675,742 | 9.08% | 0.02% |
| Dec. 17, 2025 | Moriarty John B | Chief Legal Officer | A | Common Stock | 56000 | $0.00 | 103,755.0000 | 150,675,742 | 117.27% | 0.04% |
| Dec. 17, 2025 | Moriarty John B | Chief Legal Officer | F | Common Stock | 26824 | $71.87 | 76,931.0000 | 150,675,742 | 25.85% | 0.02% |
| Dec. 17, 2025 | Gallagher Kathleen P. | Chief Program Officer | A | Common Stock | 72000 | $0.00 | 122,204.0000 | 150,675,742 | 143.41% | 0.05% |
| Dec. 17, 2025 | Gallagher Kathleen P. | Chief Program Officer | F | Common Stock | 33336 | $71.87 | 88,868.0000 | 150,675,742 | 27.28% | 0.02% |
| Dec. 17, 2025 | Gallagher Kathleen P. | Chief Program Officer | F | Common Stock | 8030 | $71.87 | 80,838.0000 | 150,675,742 | 9.04% | 0.01% |
| Dec. 17, 2025 | McCarthy Teresa | Chief Human Resources Officer | A | Common Stock | 39000 | $0.00 | 136,130.0000 | 150,675,742 | 40.15% | 0.03% |
| Oct. 22, 2025 | Hughes Steven George | Chief Medical Officer | M | Common Stock | 2209 | $10.16 | 41,076.0000 | 120,212,301 | 5.68% | 0.00% |
| Oct. 22, 2025 | Hughes Steven George | Chief Medical Officer | M | Stock Option (Right to Buy) | 2209 | $0.00 | 68,458.0000 | 120,212,301 | 3.13% | 0.00% |
| Oct. 22, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 2209 | $47.54 | 38,867.0000 | 120,212,301 | 5.38% | 0.00% |
| Oct. 15, 2025 | McCarthy Teresa | Chief Human Resources Officer | M | Common Stock | 20000 | $22.34 | 117,130.0000 | 120,212,301 | 20.59% | 0.02% |
| Oct. 15, 2025 | McCarthy Teresa | Chief Human Resources Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 65,000.0000 | 120,212,301 | 23.53% | 0.02% |
| Oct. 15, 2025 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 20000 | $50.15 | 97,130.0000 | 120,212,301 | 17.08% | 0.02% |
| Oct. 3, 2025 | Mosbrooker Eric | Chief Commercial Officer | M | Common Stock | 6562 | $9.05 | 61,562.0000 | 120,212,301 | 11.93% | 0.01% |
| Oct. 3, 2025 | Mosbrooker Eric | Chief Commercial Officer | M | Stock Option (Right to Buy) | 6562 | $0.00 | 177,188.0000 | 120,212,301 | 3.57% | 0.01% |
| Oct. 3, 2025 | Mosbrooker Eric | Chief Commercial Officer | S | Common Stock | 6562 | $45.38 | 55,000.0000 | 120,212,301 | 10.66% | 0.01% |
| Sept. 22, 2025 | Hughes Steven George | Chief Medical Officer | M | Common Stock | 2208 | $10.16 | 41,075.0000 | 120,212,301 | 5.68% | 0.00% |
| Sept. 22, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 2208 | $40.58 | 38,867.0000 | 120,212,301 | 5.38% | 0.00% |
| Sept. 22, 2025 | Hughes Steven George | Chief Medical Officer | M | Stock Option (Right to Buy) | 2208 | $0.00 | 70,667.0000 | 120,212,301 | 3.03% | 0.00% |
| Sept. 15, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 1542 | $45.41 | 38,867.0000 | 120,212,301 | 3.82% | 0.00% |
| Sept. 15, 2025 | McCarthy Teresa | Chief Human Resources Officer | M | Common Stock | 15000 | $22.34 | 112,130.0000 | 120,212,301 | 15.44% | 0.01% |
| Sept. 15, 2025 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 15000 | $41.41 | 97,130.0000 | 120,212,301 | 13.38% | 0.01% |
| Sept. 15, 2025 | McCarthy Teresa | Chief Human Resources Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 85,000.0000 | 120,212,301 | 15.00% | 0.01% |
| Sept. 15, 2025 | Hughes Steven George | Chief Medical Officer | M | Common Stock | 1542 | $6.57 | 40,409.0000 | 120,212,301 | 3.97% | 0.00% |
| Sept. 15, 2025 | Hughes Steven George | Chief Medical Officer | M | Stock Option (Right to Buy) | 1542 | $0.00 | 49,333.0000 | 120,212,301 | 3.03% | 0.00% |
| Sept. 11, 2025 | Flanagan W. Michael | Chief Scientific Officer | S | Common Stock | 20000 | $38.94 | 80,195.0000 | 120,212,301 | 19.96% | 0.02% |
| Sept. 11, 2025 | Flanagan W. Michael | Chief Scientific Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 76,500.0000 | 120,212,301 | 20.73% | 0.02% |
| Sept. 11, 2025 | Flanagan W. Michael | Chief Scientific Officer | M | Common Stock | 20000 | $14.22 | 100,195.0000 | 120,212,301 | 24.94% | 0.02% |
| Sept. 5, 2025 | WILSON TROY EDWARD | Director | S | Common Stock | 15000 | $50.00 | 68,136.0000 | 120,212,301 | 18.04% | 0.01% |
| Sept. 5, 2025 | WILSON TROY EDWARD | Director | S | Common Stock | 14500 | $50.00 | 83,136.0000 | 120,212,301 | 14.85% | 0.01% |
| Sept. 5, 2025 | WILSON TROY EDWARD | Director | M | Stock Option (Right to Buy) | 14500 | $0.00 | 0.0000 | 120,212,301 | 100.00% | 0.01% |
| Sept. 5, 2025 | WILSON TROY EDWARD | Director | M | Common Stock | 14500 | $12.48 | 97,636.0000 | 120,212,301 | 17.44% | 0.01% |
| Sept. 3, 2025 | Mosbrooker Eric | Chief Commercial Officer | M | Common Stock | 6563 | $9.05 | 61,563.0000 | 120,212,301 | 11.93% | 0.01% |
| Sept. 5, 2025 | Boyce Sarah | President and CEO | S | Common Stock | 50000 | $49.95 | 305,871.0000 | 120,212,301 | 14.05% | 0.04% |
| Sept. 5, 2025 | Boyce Sarah | President and CEO | M | Common Stock | 50000 | $1.24 | 355,871.0000 | 120,212,301 | 16.35% | 0.04% |
| Sept. 3, 2025 | Mosbrooker Eric | Chief Commercial Officer | M | Stock Option (Right to Buy) | 6563 | $0.00 | 183,750.0000 | 120,212,301 | 3.45% | 0.01% |
| Sept. 3, 2025 | Mosbrooker Eric | Chief Commercial Officer | S | Common Stock | 6563 | $47.07 | 55,000.0000 | 120,212,301 | 10.66% | 0.01% |
| Sept. 5, 2025 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 50000 | $0.00 | 1,022,015.0000 | 120,212,301 | 4.66% | 0.04% |
| Sept. 2, 2025 | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 188 | $47.42 | 50,204.0000 | 120,212,301 | 0.37% | 0.00% |
| Aug. 28, 2025 | Boyce Sarah | President and CEO | S | Common Stock | 25000 | $49.39 | 305,871.0000 | 120,212,301 | 7.56% | 0.02% |
| Aug. 28, 2025 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 1,072,015.0000 | 120,212,301 | 2.28% | 0.02% |
| Aug. 28, 2025 | Boyce Sarah | President and CEO | M | Common Stock | 25000 | $1.24 | 330,871.0000 | 120,212,301 | 8.17% | 0.02% |
| Aug. 22, 2025 | Hughes Steven George | Chief Medical Officer | M | Common Stock | 2208 | $10.16 | 41,075.0000 | 120,212,301 | 5.68% | 0.00% |
| Aug. 22, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 2208 | $46.40 | 38,867.0000 | 120,212,301 | 5.38% | 0.00% |
| Aug. 22, 2025 | Hughes Steven George | Chief Medical Officer | M | Stock Option (Right to Buy) | 2208 | $0.00 | 72,875.0000 | 120,212,301 | 2.94% | 0.00% |
| Aug. 6, 2025 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 30914 | $42.73 | 65,806.0000 | 120,212,301 | 31.96% | 0.03% |
| Aug. 13, 2025 | Hughes Steven George | Chief Medical Officer | M | Common Stock | 1542 | $6.57 | 40,409.0000 | 120,212,301 | 3.97% | 0.00% |
| Aug. 13, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 1542 | $46.66 | 38,867.0000 | 120,212,301 | 3.82% | 0.00% |
| Aug. 13, 2025 | Hughes Steven George | Chief Medical Officer | M | Stock Option (Right to Buy) | 1542 | $0.00 | 50,875.0000 | 120,212,301 | 2.94% | 0.00% |
| Aug. 15, 2025 | McCarthy Teresa | Chief Human Resources Officer | M | Common Stock | 10000 | $22.34 | 107,130.0000 | 120,212,301 | 10.30% | 0.01% |
| Aug. 15, 2025 | McCarthy Teresa | Chief Human Resources Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 100,000.0000 | 120,212,301 | 9.09% | 0.01% |
| Aug. 15, 2025 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 10000 | $46.56 | 97,130.0000 | 120,212,301 | 9.33% | 0.01% |
| Aug. 6, 2025 | WILSON TROY EDWARD | Director | S | Common Stock | 15000 | $45.00 | 712,390.0000 | 120,212,301 | 2.06% | 0.01% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | M | Stock Option (Right to Buy) | 17667 | $0.00 | 75,083.0000 | 120,212,301 | 19.05% | 0.01% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | M | Stock Option (Right to Buy) | 6167 | $0.00 | 74,000.0000 | 120,212,301 | 7.69% | 0.01% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | M | Stock Option (Right to Buy) | 12334 | $0.00 | 52,417.0000 | 120,212,301 | 19.05% | 0.01% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | M | Stock Option (Right to Buy) | 11283 | $0.00 | 73,342.0000 | 120,212,301 | 13.33% | 0.01% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 33983 | $42.74 | 38,867.0000 | 120,212,301 | 46.65% | 0.03% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 17667 | $42.74 | 72,850.0000 | 120,212,301 | 19.52% | 0.01% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | M | Common Stock | 17667 | $10.16 | 90,517.0000 | 120,212,301 | 24.25% | 0.01% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 6167 | $42.74 | 72,850.0000 | 120,212,301 | 7.80% | 0.01% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | M | Common Stock | 6167 | $22.47 | 79,017.0000 | 120,212,301 | 8.47% | 0.01% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 12334 | $42.74 | 72,850.0000 | 120,212,301 | 14.48% | 0.01% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | M | Common Stock | 12334 | $6.57 | 85,184.0000 | 120,212,301 | 16.93% | 0.01% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 11283 | $42.74 | 72,850.0000 | 120,212,301 | 13.41% | 0.01% |
| Aug. 6, 2025 | Hughes Steven George | Chief Medical Officer | M | Common Stock | 11283 | $15.96 | 84,133.0000 | 120,212,301 | 15.49% | 0.01% |
| Aug. 6, 2025 | LEVIN ARTHUR A | Director | M | Stock Option (Right to Buy) | 107500 | $0.00 | 12,500.0000 | 120,212,301 | 89.58% | 0.09% |
| Aug. 6, 2025 | LEVIN ARTHUR A | Director | S | Common Stock | 107500 | $47.62 | 173,522.0000 | 120,212,301 | 38.25% | 0.09% |
| Aug. 6, 2025 | LEVIN ARTHUR A | Director | M | Common Stock | 107500 | $22.34 | 281,022.0000 | 120,212,301 | 61.95% | 0.09% |
| Aug. 6, 2025 | WILSON TROY EDWARD | Director | M | Stock Option (Right to Buy) | 7500 | $0.00 | 14,500.0000 | 120,212,301 | 34.09% | 0.01% |
| Aug. 6, 2025 | WILSON TROY EDWARD | Director | M | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 120,212,301 | 100.00% | 0.02% |
| Aug. 6, 2025 | WILSON TROY EDWARD | Director | S | Common Stock | 17777 | $45.00 | 712,390.0000 | 120,212,301 | 2.43% | 0.01% |
| Aug. 6, 2025 | WILSON TROY EDWARD | Director | S | Common Stock | 17777 | $45.00 | 712,390.0000 | 120,212,301 | 2.43% | 0.01% |
| Aug. 6, 2025 | WILSON TROY EDWARD | Director | S | Common Stock | 15000 | $45.00 | 712,390.0000 | 120,212,301 | 2.06% | 0.01% |
| Aug. 6, 2025 | WILSON TROY EDWARD | Director | S | Common Stock | 7500 | $45.00 | 712,390.0000 | 120,212,301 | 1.04% | 0.01% |
| Aug. 6, 2025 | WILSON TROY EDWARD | Director | M | Common Stock | 7500 | $12.48 | 719,890.0000 | 120,212,301 | 1.05% | 0.01% |
| Aug. 6, 2025 | WILSON TROY EDWARD | Director | S | Common Stock | 22000 | $45.00 | 712,390.0000 | 120,212,301 | 3.00% | 0.02% |
| Aug. 6, 2025 | WILSON TROY EDWARD | Director | M | Common Stock | 22000 | $12.03 | 734,390.0000 | 120,212,301 | 3.09% | 0.02% |
| Aug. 6, 2025 | Mosbrooker Eric | Chief Commercial Officer | M | Stock Option (Right to Buy) | 124687 | $0.00 | 190,313.0000 | 120,212,301 | 39.58% | 0.10% |
| Aug. 6, 2025 | Mosbrooker Eric | Chief Commercial Officer | S | Common Stock | 6120 | $44.06 | 55,000.0000 | 120,212,301 | 10.01% | 0.01% |
| Aug. 6, 2025 | Mosbrooker Eric | Chief Commercial Officer | S | Common Stock | 124687 | $44.06 | 61,120.0000 | 120,212,301 | 67.11% | 0.10% |
| Aug. 6, 2025 | Mosbrooker Eric | Chief Commercial Officer | M | Common Stock | 124687 | $9.05 | 185,807.0000 | 120,212,301 | 204.00% | 0.10% |
| Aug. 4, 2025 | Moriarty John B | Chief Legal Officer | S | Common Stock | 2245 | $36.21 | 47,755.0000 | 120,212,301 | 4.49% | 0.00% |
| June 17, 2025 | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 911 | $30.24 | 50,392.0000 | 120,212,301 | 1.78% | 0.00% |
| June 10, 2025 | Henig Noreen | Director | A | Common Stock | 6692 | $0.00 | 6,692.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | Henig Noreen | Director | A | Stock Option (Right to Buy) | 10034 | $0.00 | 10,034.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | BOESS CARSTEN | Director | A | Common Stock | 6692 | $0.00 | 6,692.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | BOESS CARSTEN | Director | A | Stock Option (Right to Buy) | 10034 | $0.00 | 10,034.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | Kaye Edward M. MD | Director | A | Common Stock | 6692 | $0.00 | 6,692.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | Kaye Edward M. MD | Director | A | Stock Option (Right to Buy) | 10034 | $0.00 | 10,034.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | LEVIN ARTHUR A | Director | A | Common Stock | 6692 | $0.00 | 151,022.0000 | 120,212,301 | 4.64% | 0.01% |
| June 10, 2025 | LEVIN ARTHUR A | Director | A | Stock Option (Right to Buy) | 10034 | $0.00 | 10,034.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | Skerjanec Simona | Director | A | Common Stock | 6692 | $0.00 | 6,692.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | Skerjanec Simona | Director | A | Stock Option (Right to Buy) | 10034 | $0.00 | 10,034.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | WILSON TROY EDWARD | Director | A | Common Stock | 6692 | $0.00 | 69,425.0000 | 120,212,301 | 10.67% | 0.01% |
| June 10, 2025 | WILSON TROY EDWARD | Director | A | Stock Option (Right to Buy) | 10034 | $0.00 | 10,034.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | Thompson Tamar | Director | A | Common Stock | 6692 | $0.00 | 6,692.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | Thompson Tamar | Director | A | Stock Option (Right to Buy) | 10034 | $0.00 | 10,034.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | Kim Jean Jinsun | Director | A | Common Stock | 6692 | $0.00 | 6,692.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | Kim Jean Jinsun | Director | A | Stock Option (Right to Buy) | 10034 | $0.00 | 10,034.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 11, 2025 | Flanagan W. Michael | Chief Scientific Officer | M | Common Stock | 20000 | $14.22 | 100,195.0000 | 120,212,301 | 24.94% | 0.02% |
| June 11, 2025 | Flanagan W. Michael | Chief Scientific Officer | S | Common Stock | 20000 | $32.88 | 80,195.0000 | 120,212,301 | 19.96% | 0.02% |
| June 11, 2025 | Flanagan W. Michael | Chief Scientific Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 96,500.0000 | 120,212,301 | 17.17% | 0.02% |
| June 2, 2025 | Gallagher Kathleen P. | Chief Program Officer | M | Common Stock | 5875 | $16.65 | 56,429.0000 | 120,212,301 | 11.62% | 0.00% |
| June 2, 2025 | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 5875 | $32.48 | 50,554.0000 | 120,212,301 | 10.41% | 0.00% |
| June 2, 2025 | Gallagher Kathleen P. | Chief Program Officer | M | Stock Option (Right to Buy) | 5875 | $0.00 | 22,596.0000 | 120,212,301 | 20.64% | 0.00% |
| May 1, 2025 | Gallagher Kathleen P. | Chief Program Officer | M | Stock Option (Right to Buy) | 5875 | $0.00 | 28,471.0000 | 120,212,301 | 17.11% | 0.00% |
| May 1, 2025 | Gallagher Kathleen P. | Chief Program Officer | M | Common Stock | 5875 | $16.65 | 56,429.0000 | 120,212,301 | 11.62% | 0.00% |
| May 1, 2025 | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 5875 | $32.40 | 50,554.0000 | 120,212,301 | 10.41% | 0.00% |
| April 1, 2025 | Gallagher Kathleen P. | Chief Program Officer | M | Stock Option (Right to Buy) | 329 | $0.00 | 34,346.0000 | 120,212,301 | 0.95% | 0.00% |
| April 1, 2025 | Gallagher Kathleen P. | Chief Program Officer | M | Common Stock | 5546 | $14.70 | 56,100.0000 | 120,212,301 | 10.97% | 0.00% |
| April 1, 2025 | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 5546 | $27.83 | 50,554.0000 | 120,212,301 | 9.89% | 0.00% |
| April 1, 2025 | Gallagher Kathleen P. | Chief Program Officer | M | Common Stock | 329 | $16.65 | 50,883.0000 | 120,212,301 | 0.65% | 0.00% |
| April 1, 2025 | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 329 | $27.83 | 50,554.0000 | 120,212,301 | 0.65% | 0.00% |
| April 1, 2025 | Gallagher Kathleen P. | Chief Program Officer | M | Stock Option (Right to Buy) | 5546 | $0.00 | 13,829.0000 | 120,212,301 | 28.62% | 0.00% |
| March 20, 2025 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 7935 | $31.06 | 96,720.0000 | 120,212,301 | 7.58% | 0.01% |
| March 20, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 9578 | $31.06 | 72,850.0000 | 120,212,301 | 11.62% | 0.01% |
| March 20, 2025 | Boyce Sarah | President and CEO | S | Common Stock | 31540 | $31.06 | 305,871.0000 | 120,212,301 | 9.35% | 0.03% |
| March 20, 2025 | Flanagan W. Michael | Chief Scientific Officer | S | Common Stock | 11780 | $31.06 | 80,195.0000 | 120,212,301 | 12.81% | 0.01% |
| March 20, 2025 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 7778 | $31.06 | 97,130.0000 | 120,212,301 | 7.41% | 0.01% |
| March 11, 2025 | Flanagan W. Michael | Chief Scientific Officer | S | Common Stock | 20000 | $30.13 | 91,975.0000 | 120,212,301 | 17.86% | 0.02% |
| March 11, 2025 | Flanagan W. Michael | Chief Scientific Officer | M | Common Stock | 20000 | $14.22 | 111,975.0000 | 120,212,301 | 21.75% | 0.02% |
| March 11, 2025 | Flanagan W. Michael | Chief Scientific Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 116,500.0000 | 120,212,301 | 14.65% | 0.02% |
| March 3, 2025 | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 5875 | $29.41 | 50,554.0000 | 120,212,301 | 10.41% | 0.00% |
| March 3, 2025 | Gallagher Kathleen P. | Chief Program Officer | M | Common Stock | 5875 | $14.70 | 56,429.0000 | 120,212,301 | 11.62% | 0.00% |
| March 3, 2025 | Gallagher Kathleen P. | Chief Program Officer | M | Stock Option (Right to Buy) | 5875 | $0.00 | 19,375.0000 | 120,212,301 | 23.27% | 0.00% |
| Feb. 3, 2025 | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 5875 | $32.16 | 50,554.0000 | 0 | 10.41% | 0.00% |
| Feb. 3, 2025 | Gallagher Kathleen P. | Chief Program Officer | M | Common Stock | 5875 | $16.65 | 56,429.0000 | 0 | 11.62% | 0.00% |
| Feb. 3, 2025 | Gallagher Kathleen P. | Chief Program Officer | M | Stock Option (Right to Buy) | 5875 | $0.00 | 34,675.0000 | 0 | 14.49% | 0.00% |
| Jan. 21, 2025 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 1738 | $28.59 | 106,129.0000 | 0 | 1.61% | 0.00% |
| Jan. 21, 2025 | LEVIN ARTHUR A | Director | S | Common Stock | 1872 | $28.60 | 144,330.0000 | 0 | 1.28% | 0.00% |
| Jan. 21, 2025 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 1622 | $28.59 | 106,320.0000 | 0 | 1.50% | 0.00% |
| Jan. 21, 2025 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 1665 | $28.59 | 104,655.0000 | 0 | 1.57% | 0.00% |
| Jan. 21, 2025 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 1221 | $28.60 | 104,908.0000 | 0 | 1.15% | 0.00% |
| Jan. 21, 2025 | Flanagan W. Michael | Chief Scientific Officer | S | Common Stock | 3860 | $28.60 | 93,787.0000 | 0 | 3.95% | 0.00% |
| Jan. 21, 2025 | Flanagan W. Michael | Chief Scientific Officer | S | Common Stock | 1812 | $28.59 | 91,975.0000 | 0 | 1.93% | 0.00% |
| Jan. 21, 2025 | Boyce Sarah | President and CEO | S | Common Stock | 4738 | $28.59 | 343,070.0000 | 0 | 1.36% | 0.00% |
| Jan. 21, 2025 | Boyce Sarah | President and CEO | S | Common Stock | 5659 | $28.59 | 337,411.0000 | 0 | 1.65% | 0.00% |
| Jan. 21, 2025 | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 1295 | $28.59 | 58,670.0000 | 0 | 2.16% | 0.00% |
| Jan. 21, 2025 | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 670 | $28.60 | 58,000.0000 | 0 | 1.14% | 0.00% |
| Jan. 21, 2025 | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 1817 | $28.59 | 56,183.0000 | 0 | 3.13% | 0.00% |
| Jan. 22, 2025 | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 5629 | $30.16 | 50,554.0000 | 0 | 10.02% | 0.00% |
| Jan. 21, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 1915 | $28.60 | 84,460.0000 | 0 | 2.22% | 0.00% |
| Jan. 21, 2025 | Hughes Steven George | Chief Medical Officer | S | Common Stock | 2032 | $28.59 | 82,428.0000 | 0 | 2.41% | 0.00% |
| Jan. 6, 2025 | Calderaro Charles III | Chief Technical Officer | A | Common Stock | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Calderaro Charles III | Chief Technical Officer | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Flanagan W. Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | McCarthy Teresa | Chief Human Resources Officer | A | Common Stock | 25000 | $0.00 | 107,867.0000 | 0 | 30.17% | 0.00% |
| Jan. 6, 2025 | McCarthy Teresa | Chief Human Resources Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Moriarty John B | Chief Legal Officer | A | Common Stock | 25000 | $0.00 | 50,000.0000 | 0 | 100.00% | 0.00% |
| Jan. 6, 2025 | Moriarty John B | Chief Legal Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | MacLean Michael F | Chief Financial Officer | A | Common Stock | 25000 | $0.00 | 107,942.0000 | 0 | 30.14% | 0.00% |
| Jan. 6, 2025 | MacLean Michael F | Chief Financial Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Boyce Sarah | President and CEO | A | Common Stock | 82500 | $0.00 | 347,808.0000 | 0 | 31.10% | 0.00% |
| Jan. 6, 2025 | Boyce Sarah | President and CEO | A | Stock Option (Right to Buy) | 165000 | $0.00 | 165,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Hughes Steven George | Chief Medical Officer | A | Common Stock | 25000 | $0.00 | 86,375.0000 | 0 | 40.73% | 0.00% |
| Jan. 6, 2025 | Hughes Steven George | Chief Medical Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Gallagher Kathleen P. | Chief Program Officer | A | Common Stock | 25000 | $0.00 | 59,965.0000 | 0 | 71.50% | 0.00% |
| Jan. 6, 2025 | Gallagher Kathleen P. | Chief Program Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Mosbrooker Eric | Chief Commercial Officer | A | Common Stock | 25000 | $0.00 | 61,120.0000 | 0 | 69.21% | 0.00% |
| Jan. 6, 2025 | Mosbrooker Eric | Chief Commercial Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Flanagan W. Michael | Chief Scientific Officer | A | Common Stock | 25000 | $0.00 | 97,647.0000 | 0 | 34.41% | 0.00% |
| Dec. 18, 2024 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 11151 | $32.66 | 82,942.0000 | 0 | 11.85% | 0.00% |
| Dec. 18, 2024 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 11151 | $32.66 | 82,867.0000 | 0 | 11.86% | 0.00% |
| Dec. 18, 2024 | Flanagan W. Michael | CSTO | S | Common Stock | 12742 | $32.66 | 72,647.0000 | 0 | 14.92% | 0.00% |
| Dec. 18, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 31855 | $32.66 | 265,308.0000 | 0 | 10.72% | 0.00% |
| Dec. 16, 2024 | McCarthy Teresa | Chief Human Resources Officer | M | Common Stock | 25000 | $14.22 | 119,018.0000 | 0 | 26.59% | 0.00% |
| Dec. 16, 2024 | McCarthy Teresa | Chief Human Resources Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 57,500.0000 | 0 | 30.30% | 0.00% |
| Dec. 16, 2024 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 25000 | $33.26 | 94,018.0000 | 0 | 21.01% | 0.00% |
| Dec. 11, 2024 | Flanagan W. Michael | CSTO | M | Common Stock | 24000 | $22.47 | 109,389.0000 | 0 | 28.11% | 0.00% |
| Dec. 11, 2024 | Flanagan W. Michael | CSTO | M | Stock Option (Right to Buy) | 24000 | $0.00 | 86,000.0000 | 0 | 21.82% | 0.00% |
| Dec. 11, 2024 | Flanagan W. Michael | CSTO | S | Common Stock | 24000 | $35.77 | 85,389.0000 | 0 | 21.94% | 0.00% |
| Nov. 18, 2024 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 25000 | $41.14 | 94,018.0000 | 0 | 21.01% | 0.00% |
| Nov. 18, 2024 | McCarthy Teresa | Chief Human Resources Officer | M | Common Stock | 25000 | $14.22 | 119,018.0000 | 0 | 26.59% | 0.00% |
| Nov. 18, 2024 | McCarthy Teresa | Chief Human Resources Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 82,500.0000 | 0 | 23.26% | 0.00% |
| Nov. 19, 2024 | LEVIN ARTHUR A | Director | M | Common Stock | 3323 | $1.24 | 149,525.0000 | 0 | 2.27% | 0.00% |
| Nov. 19, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 3323 | $42.12 | 146,202.0000 | 0 | 2.22% | 0.00% |
| Nov. 19, 2024 | LEVIN ARTHUR A | Director | M | Stock Option (Right to Buy) | 3323 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 6, 2024 | MacLean Michael F | Chief Financial Officer | M | Stock Option (Right to Buy) | 13875 | $0.00 | 60,125.0000 | 0 | 18.75% | 0.00% |
| Nov. 6, 2024 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 27262 | $46.22 | 94,093.0000 | 0 | 22.46% | 0.00% |
| Nov. 6, 2024 | MacLean Michael F | Chief Financial Officer | M | Common Stock | 65182 | $8.82 | 159,275.0000 | 0 | 69.27% | 0.00% |
| Nov. 6, 2024 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 65182 | $45.33 | 94,093.0000 | 0 | 40.92% | 0.00% |
| Nov. 6, 2024 | MacLean Michael F | Chief Financial Officer | M | Common Stock | 13875 | $6.57 | 107,968.0000 | 0 | 14.75% | 0.00% |
| Nov. 6, 2024 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 13875 | $45.33 | 94,093.0000 | 0 | 12.85% | 0.00% |
| Nov. 6, 2024 | MacLean Michael F | Chief Financial Officer | M | Stock Option (Right to Buy) | 65182 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 21, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 5000 | $46.63 | 146,202.0000 | 0 | 3.31% | 0.00% |
| Oct. 21, 2024 | LEVIN ARTHUR A | Director | M | Common Stock | 5000 | $1.24 | 151,202.0000 | 0 | 3.42% | 0.00% |
| Oct. 21, 2024 | LEVIN ARTHUR A | Director | M | Stock Option (Right to Buy) | 5000 | $0.00 | 3,323.0000 | 0 | 60.07% | 0.00% |
| Oct. 16, 2024 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 25000 | $48.52 | 94,018.0000 | 0 | 21.01% | 0.00% |
| Oct. 16, 2024 | McCarthy Teresa | Chief Human Resources Officer | M | Common Stock | 25000 | $14.22 | 119,018.0000 | 0 | 26.59% | 0.00% |
| Oct. 16, 2024 | McCarthy Teresa | Chief Human Resources Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 107,500.0000 | 0 | 18.87% | 0.00% |
| Oct. 7, 2024 | Thompson Tamar | Director | S | Common Stock | 30000 | $44.98 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 7, 2024 | Thompson Tamar | Director | M | Common Stock | 30000 | $27.63 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 7, 2024 | Thompson Tamar | Director | M | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 1, 2024 | Flanagan W. Michael | CSTO | S | Common Stock | 62500 | $47.62 | 85,389.0000 | 0 | 42.26% | 0.00% |
| Oct. 1, 2024 | Flanagan W. Michael | CSTO | M | Common Stock | 62500 | $26.75 | 147,889.0000 | 0 | 73.19% | 0.00% |
| Oct. 1, 2024 | Flanagan W. Michael | CSTO | M | Stock Option (Right to Buy) | 62500 | $0.00 | 25,000.0000 | 0 | 71.43% | 0.00% |
| Sept. 19, 2024 | Flanagan W. Michael | CSTO | A | Common Stock | 25000 | $0.00 | 85,871.0000 | 0 | 41.07% | 0.00% |
| Sept. 19, 2024 | McCarthy Teresa | Chief Human Resources Officer | A | Common Stock | 25000 | $0.00 | 82,171.0000 | 0 | 43.73% | 0.00% |
| Sept. 23, 2024 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 13153 | $44.00 | 69,018.0000 | 0 | 16.01% | 0.00% |
| Sept. 19, 2024 | McCarthy Teresa | Chief Human Resources Officer | A | Common Stock | 25000 | $0.00 | 94,018.0000 | 0 | 36.22% | 0.00% |
| Sept. 23, 2024 | Flanagan W. Michael | CSTO | S | Common Stock | 13153 | $44.00 | 72,718.0000 | 0 | 15.32% | 0.00% |
| Sept. 19, 2024 | Flanagan W. Michael | CSTO | A | Common Stock | 25000 | $0.00 | 97,718.0000 | 0 | 34.38% | 0.00% |
| Sept. 23, 2024 | Flanagan W. Michael | CSTO | S | Common Stock | 11847 | $43.89 | 85,389.0000 | 0 | 12.18% | 0.00% |
| Sept. 19, 2024 | Boyce Sarah | President and CEO | A | Common Stock | 62500 | $0.00 | 267,543.0000 | 0 | 30.48% | 0.00% |
| Sept. 23, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 32880 | $44.00 | 234,663.0000 | 0 | 12.29% | 0.00% |
| Sept. 19, 2024 | Boyce Sarah | President and CEO | A | Common Stock | 62500 | $0.00 | 297,163.0000 | 0 | 26.63% | 0.00% |
| Sept. 19, 2024 | MacLean Michael F | Chief Financial Officer | A | Common Stock | 25000 | $0.00 | 107,865.0000 | 0 | 30.17% | 0.00% |
| Sept. 23, 2024 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 11510 | $44.00 | 96,355.0000 | 0 | 10.67% | 0.00% |
| Sept. 19, 2024 | MacLean Michael F | Chief Financial Officer | A | Common Stock | 25000 | $0.00 | 121,355.0000 | 0 | 25.95% | 0.00% |
| Sept. 19, 2024 | LEVIN ARTHUR A | Director | M | Common Stock | 5000 | $1.24 | 151,202.0000 | 0 | 3.42% | 0.00% |
| Sept. 19, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 5000 | $45.73 | 146,202.0000 | 0 | 3.31% | 0.00% |
| Sept. 19, 2024 | LEVIN ARTHUR A | Director | M | Stock Option (Right to Buy) | 5000 | $0.00 | 8,323.0000 | 0 | 37.53% | 0.00% |
| Sept. 11, 2024 | Flanagan W. Michael | CSTO | M | Common Stock | 34000 | $22.47 | 109,765.0000 | 0 | 44.88% | 0.00% |
| Sept. 11, 2024 | Flanagan W. Michael | CSTO | S | Common Stock | 34000 | $40.40 | 75,765.0000 | 0 | 30.98% | 0.00% |
| Sept. 11, 2024 | Flanagan W. Michael | CSTO | S | Common Stock | 14894 | $40.40 | 60,871.0000 | 0 | 19.66% | 0.00% |
| Sept. 11, 2024 | Flanagan W. Michael | CSTO | M | Stock Option (Right to Buy) | 62500 | $0.00 | 87,500.0000 | 0 | 41.67% | 0.00% |
| Sept. 11, 2024 | Flanagan W. Michael | CSTO | M | Stock Option (Right to Buy) | 34000 | $0.00 | 110,000.0000 | 0 | 23.61% | 0.00% |
| Sept. 11, 2024 | McCarthy Teresa | Chief Human Resources Officer | M | Common Stock | 25000 | $14.22 | 82,171.0000 | 0 | 43.73% | 0.00% |
| Sept. 11, 2024 | McCarthy Teresa | Chief Human Resources Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 132,500.0000 | 0 | 15.87% | 0.00% |
| Sept. 11, 2024 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 25000 | $40.40 | 57,171.0000 | 0 | 30.42% | 0.00% |
| Sept. 11, 2024 | Flanagan W. Michael | CSTO | M | Common Stock | 62500 | $26.75 | 138,265.0000 | 0 | 82.49% | 0.00% |
| Sept. 11, 2024 | Flanagan W. Michael | CSTO | S | Common Stock | 62500 | $40.40 | 75,765.0000 | 0 | 45.20% | 0.00% |
| Sept. 6, 2024 | LEVIN ARTHUR A | Director | G | Common Stock | 22500 | $0.00 | 168,702.0000 | 0 | 11.77% | 0.00% |
| Sept. 6, 2024 | LEVIN ARTHUR A | Director | G | Common Stock | 22500 | $0.00 | 168,702.0000 | 0 | 15.39% | 0.00% |
| Aug. 19, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 5000 | $45.19 | 168,702.0000 | 0 | 2.88% | 0.00% |
| Aug. 19, 2024 | LEVIN ARTHUR A | Director | M | Common Stock | 5000 | $1.24 | 173,702.0000 | 0 | 2.96% | 0.00% |
| Aug. 19, 2024 | LEVIN ARTHUR A | Director | M | Stock Option (Right to Buy) | 5000 | $0.00 | 13,323.0000 | 0 | 27.29% | 0.00% |
| Aug. 6, 2024 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 28000 | $0.00 | 461,015.0000 | 0 | 5.73% | 0.00% |
| Aug. 6, 2024 | Boyce Sarah | President and CEO | M | Common Stock | 28000 | $1.24 | 233,043.0000 | 0 | 13.66% | 0.00% |
| Aug. 6, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 28000 | $43.35 | 205,043.0000 | 0 | 12.01% | 0.00% |
| Aug. 1, 2024 | Moriarty John B | Chief Legal Officer | A | Common Stock | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2024 | Moriarty John B | Chief Legal Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2024 | LEVIN ARTHUR A | Director | M | Stock Option (Right to Buy) | 5000 | $0.00 | 18,323.0000 | 0 | 21.44% | 0.00% |
| July 19, 2024 | LEVIN ARTHUR A | Director | M | Common Stock | 5000 | $1.24 | 173,702.0000 | 0 | 2.96% | 0.00% |
| July 19, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 5000 | $45.01 | 168,702.0000 | 0 | 2.88% | 0.00% |
| July 9, 2024 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 28000 | $0.00 | 489,015.0000 | 0 | 5.42% | 0.00% |
| July 9, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 28000 | $39.93 | 205,043.0000 | 0 | 12.01% | 0.00% |
| July 9, 2024 | Boyce Sarah | President and CEO | M | Common Stock | 28000 | $1.24 | 233,043.0000 | 0 | 13.66% | 0.00% |
| June 20, 2024 | LEVIN ARTHUR A | Director | M | Stock Option (Right to Buy) | 5000 | $0.00 | 23,323.0000 | 0 | 17.65% | 0.00% |
| June 20, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 5000 | $37.59 | 168,702.0000 | 0 | 2.88% | 0.00% |
| June 20, 2024 | LEVIN ARTHUR A | Director | M | Common Stock | 5000 | $1.24 | 173,702.0000 | 0 | 2.96% | 0.00% |
| June 17, 2024 | Boyce Sarah | President and CEO | A | Common Stock | 62500 | $0.00 | 205,043.0000 | 0 | 43.85% | 0.00% |
| June 18, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 32074 | $39.13 | 142,543.0000 | 0 | 18.37% | 0.00% |
| June 17, 2024 | Boyce Sarah | President and CEO | A | Common Stock | 62500 | $0.00 | 174,617.0000 | 0 | 55.75% | 0.00% |
| June 17, 2024 | McCarthy Teresa | Chief Human Resources Officer | A | Common Stock | 25000 | $0.00 | 57,171.0000 | 0 | 77.71% | 0.00% |
| June 17, 2024 | MacLean Michael F | Chief Financial Officer | A | Common Stock | 25000 | $0.00 | 69,093.0000 | 0 | 56.70% | 0.00% |
| June 18, 2024 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 11228 | $39.13 | 57,865.0000 | 0 | 16.25% | 0.00% |
| June 17, 2024 | MacLean Michael F | Chief Financial Officer | A | Common Stock | 25000 | $0.00 | 82,865.0000 | 0 | 43.20% | 0.00% |
| June 17, 2024 | Flanagan W. Michael | CSTO | A | Common Stock | 25000 | $0.00 | 60,871.0000 | 0 | 69.69% | 0.00% |
| June 17, 2024 | McCarthy Teresa | Chief Human Resources Officer | A | Common Stock | 25000 | $0.00 | 42,035.0000 | 0 | 146.76% | 0.00% |
| June 18, 2024 | Flanagan W. Michael | CSTO | S | Common Stock | 10106 | $39.13 | 50,765.0000 | 0 | 16.60% | 0.00% |
| June 18, 2024 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 9864 | $39.13 | 32,171.0000 | 0 | 23.47% | 0.00% |
| June 17, 2024 | Flanagan W. Michael | CSTO | A | Common Stock | 25000 | $0.00 | 75,765.0000 | 0 | 49.25% | 0.00% |
| June 12, 2024 | Boyce Sarah | President and CEO | M | Common Stock | 100000 | $1.24 | 212,117.0000 | 0 | 89.19% | 0.00% |
| June 12, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 100000 | $35.73 | 112,117.0000 | 0 | 47.14% | 0.00% |
| June 13, 2024 | Boyce Sarah | President and CEO | M | Common Stock | 164233 | $1.24 | 276,350.0000 | 0 | 146.48% | 0.00% |
| June 13, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 164233 | $40.08 | 112,117.0000 | 0 | 59.43% | 0.00% |
| June 14, 2024 | Boyce Sarah | President and CEO | M | Common Stock | 35767 | $1.24 | 147,884.0000 | 0 | 31.90% | 0.00% |
| June 14, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 35767 | $40.08 | 112,117.0000 | 0 | 24.19% | 0.00% |
| June 13, 2024 | Thompson Tamar | Director | A | Stock Option (Right to Buy) | 13489 | $0.00 | 13,490.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 164233 | $0.00 | 552,782.0000 | 0 | 22.91% | 0.00% |
| June 12, 2024 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 717,015.0000 | 0 | 12.24% | 0.00% |
| June 13, 2024 | Kaye Edward M. MD | Director | A | Stock Option (Right to Buy) | 13489 | $0.00 | 13,489.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | MacLean Michael F | Chief Financial Officer | M | Common Stock | 104245 | $8.82 | 148,338.0000 | 0 | 236.42% | 0.00% |
| June 12, 2024 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 104245 | $35.72 | 44,093.0000 | 0 | 70.28% | 0.00% |
| June 12, 2024 | MacLean Michael F | Chief Financial Officer | M | Stock Option (Right to Buy) | 104245 | $0.00 | 65,182.0000 | 0 | 61.53% | 0.00% |
| June 13, 2024 | Kim Jean Jinsun | Director | A | Stock Option (Right to Buy) | 13489 | $0.00 | 13,489.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 40000 | $35.07 | 228,702.0000 | 0 | 14.89% | 0.00% |
| June 13, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 60000 | $40.08 | 168,702.0000 | 0 | 26.24% | 0.00% |
| June 13, 2024 | LEVIN ARTHUR A | Director | A | Stock Option (Right to Buy) | 13489 | $0.00 | 13,489.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | BOESS CARSTEN | Director | A | Stock Option (Right to Buy) | 13489 | $0.00 | 13,489.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | WILSON TROY EDWARD | Director | A | Stock Option (Right to Buy) | 13489 | $0.00 | 13,489.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Henig Noreen | Director | A | Stock Option (Right to Buy) | 13489 | $0.00 | 13,489.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 35767 | $0.00 | 517,015.0000 | 0 | 6.47% | 0.00% |
| June 4, 2024 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 28000 | $0.00 | 817,015.0000 | 0 | 3.31% | 0.00% |
| June 4, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 28000 | $27.42 | 112,117.0000 | 0 | 19.98% | 0.00% |
| June 4, 2024 | Boyce Sarah | President and CEO | M | Common Stock | 28000 | $1.24 | 140,117.0000 | 0 | 24.97% | 0.00% |
| May 20, 2024 | LEVIN ARTHUR A | Director | M | Common Stock | 5000 | $1.24 | 273,702.0000 | 0 | 1.86% | 0.00% |
| May 20, 2024 | LEVIN ARTHUR A | Director | M | Stock Option (Right to Buy) | 5000 | $0.00 | 28,323.0000 | 0 | 15.00% | 0.00% |
| May 20, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 5000 | $29.90 | 268,702.0000 | 0 | 1.83% | 0.00% |
| May 14, 2024 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 75000 | $28.28 | 44,093.0000 | 0 | 62.98% | 0.00% |
| May 14, 2024 | MacLean Michael F | Chief Financial Officer | M | Common Stock | 75000 | $8.82 | 119,093.0000 | 0 | 170.10% | 0.00% |
| May 14, 2024 | MacLean Michael F | Chief Financial Officer | M | Stock Option (Right to Buy) | 75000 | $0.00 | 169,427.0000 | 0 | 30.68% | 0.00% |
| May 14, 2024 | Skerjanec Simona | Not found | A | Stock Option (Right to Buy) | 42308 | $0.00 | 42,308.0000 | 0 | 9999.99% | 0.00% |
| May 7, 2024 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 28000 | $0.00 | 845,015.0000 | 0 | 3.21% | 0.00% |
| May 7, 2024 | Boyce Sarah | President and CEO | M | Common Stock | 28000 | $1.24 | 140,117.0000 | 0 | 24.97% | 0.00% |
| May 7, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 28000 | $25.54 | 112,117.0000 | 0 | 19.98% | 0.00% |
| April 19, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 5000 | $22.82 | 268,702.0000 | 0 | 1.83% | 0.00% |
| April 19, 2024 | LEVIN ARTHUR A | Director | M | Common Stock | 5000 | $1.24 | 273,702.0000 | 0 | 1.86% | 0.00% |
| April 19, 2024 | LEVIN ARTHUR A | Director | M | Stock Option (Right to Buy) | 5000 | $0.00 | 33,323.0000 | 0 | 13.05% | 0.00% |
| April 2, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 28000 | $26.25 | 112,117.0000 | 0 | 19.98% | 0.00% |
| April 2, 2024 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 28000 | $0.00 | 873,015.0000 | 0 | 3.11% | 0.00% |
| April 2, 2024 | Boyce Sarah | President and CEO | M | Common Stock | 28000 | $1.24 | 140,117.0000 | 0 | 24.97% | 0.00% |
| April 3, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 20000 | $27.11 | 268,702.0000 | 0 | 6.93% | 0.00% |
| March 19, 2024 | LEVIN ARTHUR A | Director | M | Common Stock | 5000 | $1.24 | 293,702.0000 | 0 | 1.73% | 0.00% |
| March 19, 2024 | LEVIN ARTHUR A | Director | M | Stock Option (Right to Buy) | 5000 | $0.00 | 38,323.0000 | 0 | 11.54% | 0.00% |
| March 19, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 5000 | $23.97 | 288,702.0000 | 0 | 1.70% | 0.00% |
| March 13, 2024 | MacLean Michael F | Chief Financial Officer | M | Stock Option (Right to Buy) | 40000 | $0.00 | 244,427.0000 | 0 | 14.06% | 0.00% |
| March 13, 2024 | MacLean Michael F | Chief Financial Officer | M | Common Stock | 40000 | $8.82 | 84,093.0000 | 0 | 90.72% | 0.00% |
| March 13, 2024 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 40000 | $24.52 | 44,093.0000 | 0 | 47.57% | 0.00% |
| March 12, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 2641 | $22.00 | 288,702.0000 | 0 | 0.91% | 0.00% |
| March 12, 2024 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 28000 | $0.00 | 901,015.0000 | 0 | 3.01% | 0.00% |
| March 8, 2024 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 84000 | $0.00 | 929,015.0000 | 0 | 8.29% | 0.00% |
| March 12, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 28000 | $22.63 | 112,117.0000 | 0 | 19.98% | 0.00% |
| March 12, 2024 | Boyce Sarah | President and CEO | M | Common Stock | 28000 | $1.24 | 140,117.0000 | 0 | 24.97% | 0.00% |
| March 8, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 84000 | $21.39 | 112,117.0000 | 0 | 42.83% | 0.00% |
| March 8, 2024 | Boyce Sarah | President and CEO | M | Common Stock | 84000 | $1.24 | 196,117.0000 | 0 | 74.92% | 0.00% |
| March 12, 2024 | LEVIN ARTHUR A | Director | M | Stock Option (Right to Buy) | 25000 | $0.00 | 43,323.0000 | 0 | 36.59% | 0.00% |
| March 12, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 25000 | $22.04 | 291,343.0000 | 0 | 7.90% | 0.00% |
| March 12, 2024 | LEVIN ARTHUR A | Director | M | Common Stock | 25000 | $1.24 | 316,343.0000 | 0 | 8.58% | 0.00% |
| March 1, 2024 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 84000 | $0.00 | 1,013,015.0000 | 0 | 7.66% | 0.00% |
| March 1, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 84000 | $20.13 | 112,117.0000 | 0 | 42.83% | 0.00% |
| March 1, 2024 | Boyce Sarah | President and CEO | M | Common Stock | 84000 | $1.24 | 196,117.0000 | 0 | 74.92% | 0.00% |
| Jan. 22, 2024 | McCarthy Teresa | Chief Human Resources Officer | S | Common Stock | 2065 | $10.13 | 17,035.0000 | 0 | 10.81% | 0.00% |
| Jan. 20, 2024 | McCarthy Teresa | Chief Human Resources Officer | A | Common Stock | 16500 | $0.00 | 17,458.0000 | 0 | 1722.34% | 0.00% |
| Jan. 20, 2024 | Flanagan W. Michael | CSTO | A | Stock Option (Right to Buy) | 88000 | $0.00 | 88,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | MacLean Michael F | Chief Financial Officer | S | Common Stock | 1616 | $10.13 | 16,884.0000 | 0 | 8.74% | 0.00% |
| Jan. 20, 2024 | MacLean Michael F | Chief Financial Officer | A | Common Stock | 22500 | $0.00 | 27,209.0000 | 0 | 477.81% | 0.00% |
| Jan. 20, 2024 | McCarthy Teresa | Chief Human Resources Officer | A | Stock Option (Right to Buy) | 78000 | $0.00 | 78,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | LEVIN ARTHUR A | Director | S | Common Stock | 1859 | $10.13 | 291,343.0000 | 0 | 0.63% | 0.00% |
| Jan. 20, 2024 | Boyce Sarah | President and CEO | A | Common Stock | 62500 | $0.00 | 67,209.0000 | 0 | 1327.25% | 0.00% |
| Jan. 22, 2024 | Boyce Sarah | President and CEO | S | Common Stock | 5092 | $10.13 | 44,008.0000 | 0 | 10.37% | 0.00% |
| Jan. 20, 2024 | Boyce Sarah | President and CEO | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2024 | Flanagan W. Michael | CSTO | A | Common Stock | 20000 | $0.00 | 20,290.0000 | 0 | 6896.55% | 0.00% |
| Jan. 22, 2024 | Flanagan W. Michael | CSTO | S | Common Stock | 4129 | $10.13 | 35,871.0000 | 0 | 10.32% | 0.00% |
| Jan. 20, 2024 | MacLean Michael F | Chief Financial Officer | A | Stock Option (Right to Buy) | 106000 | $0.00 | 106,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 12, 2023 | WILSON TROY EDWARD | Director | J | Common Stock | 300000 | $0.00 | 771,252.0000 | 0 | 63.66% | 0.00% |
| Dec. 12, 2023 | WILSON TROY EDWARD | Director | J | Common Stock | 300000 | $0.00 | 1,021,252.0000 | 0 | 22.71% | 0.00% |
| Dec. 12, 2023 | WILSON TROY EDWARD | Director | J | Common Stock | 250000 | $0.00 | 771,252.0000 | 0 | 47.96% | 0.00% |
| Dec. 12, 2023 | WILSON TROY EDWARD | Director | J | Common Stock | 250000 | $0.00 | 771,252.0000 | 0 | 24.48% | 0.00% |
| Sept. 11, 2023 | McCarthy Teresa | Chief Human Resources Officer | A | Stock Option (Right to Buy) | 54000 | $0.00 | 54,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2023 | Boyce Sarah | President and CEO | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2023 | MacLean Michael F | Chief Financial Officer | A | Stock Option (Right to Buy) | 74000 | $0.00 | 74,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2023 | Flanagan W. Michael | CSTO | A | Stock Option (Right to Buy) | 72000 | $0.00 | 72,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | WILSON TROY EDWARD | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Kim Jean Jinsun | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Kaye Edward M. MD | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Henig Noreen | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Thompson Tamar | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | BOESS CARSTEN | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Mosbrooker Eric | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2023 | LEVIN ARTHUR A | Director | S | Common Stock | 100 | $22.01 | 293,202.0000 | 0 | 0.03% | 0.00% |
| March 15, 2023 | LEVIN ARTHUR A | Director | M | Common Stock | 100 | $1.24 | 293,302.0000 | 0 | 0.03% | 0.00% |
| March 15, 2023 | LEVIN ARTHUR A | Director | M | Stock Option (Right to Buy) | 100 | $0.00 | 68,323.0000 | 0 | 0.15% | 0.00% |
| Feb. 14, 2023 | LEVIN ARTHUR A | Chief Scientific Officer | M | Common Stock | 10000 | $1.24 | 303,202.0000 | 0 | 3.41% | 0.00% |
| Feb. 14, 2023 | LEVIN ARTHUR A | Chief Scientific Officer | S | Common Stock | 9477 | $23.62 | 293,725.0000 | 0 | 3.13% | 0.00% |
| Feb. 14, 2023 | LEVIN ARTHUR A | Chief Scientific Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 68,423.0000 | 0 | 12.75% | 0.00% |
| Feb. 14, 2023 | LEVIN ARTHUR A | Chief Scientific Officer | S | Common Stock | 523 | $24.24 | 293,202.0000 | 0 | 0.18% | 0.00% |
| Feb. 1, 2023 | Boyce Sarah | President and CEO | M | Common Stock | 900 | $1.24 | 54,252.0000 | 0 | 1.69% | 0.00% |
| Feb. 2, 2023 | Boyce Sarah | President and CEO | S | Common Stock | 45879 | $24.36 | 53,352.0000 | 0 | 46.23% | 0.00% |
| Feb. 3, 2023 | Boyce Sarah | President and CEO | M | Common Stock | 3221 | $1.24 | 56,573.0000 | 0 | 6.04% | 0.00% |
| Feb. 3, 2023 | Boyce Sarah | President and CEO | S | Common Stock | 3221 | $24.26 | 53,352.0000 | 0 | 5.69% | 0.00% |
| Feb. 3, 2023 | Boyce Sarah | President and CEO | M | Stock Option (Right to | 3221 | $0.00 | 1,097,015.0000 | 0 | 0.29% | 0.00% |
| Feb. 1, 2023 | Boyce Sarah | President and CEO | S | Common Stock | 900 | $24.27 | 53,352.0000 | 0 | 1.66% | 0.00% |
| Feb. 2, 2023 | Boyce Sarah | President and CEO | M | Common Stock | 45879 | $1.24 | 99,231.0000 | 0 | 85.99% | 0.00% |
| Feb. 2, 2023 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 45879 | $0.00 | 1,100,236.0000 | 0 | 4.00% | 0.00% |
| Feb. 1, 2023 | Boyce Sarah | President and CEO | M | Stock Option (Right to Buy) | 900 | $0.00 | 1,146,115.0000 | 0 | 0.08% | 0.00% |
| Jan. 20, 2023 | Boyce Sarah | President and CEO | A | Common Stock | 50000 | $0.00 | 53,352.0000 | 0 | 1491.65% | 0.00% |
| Jan. 20, 2023 | MacLean Michael F | Chief Financial Officer | A | Stock Option (Right to Buy) | 148000 | $0.00 | 148,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | McCarthy Teresa | Chief Human Resources Officer | A | Common Stock | 20000 | $0.00 | 20,958.0000 | 0 | 2087.68% | 0.00% |
| Jan. 20, 2023 | McCarthy Teresa | Chief Human Resources Officer | A | Stock Option (Right to Buy) | 108000 | $0.00 | 108,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | Boyce Sarah | President and CEO | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | Flanagan W. Michael | Chief Technical Officer | A | Common Stock | 40000 | $0.00 | 40,290.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | Flanagan W. Michael | Chief Technical Officer | A | Stock Option (Right to Buy) | 144000 | $0.00 | 144,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | LEVIN ARTHUR A | Chief Scientific Officer | A | Common Stock | 18000 | $0.00 | 293,202.0000 | 0 | 6.54% | 0.00% |
| Jan. 20, 2023 | LEVIN ARTHUR A | Chief Scientific Officer | A | Stock Option (Right to Buy) | 144000 | $0.00 | 144,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | MacLean Michael F | Chief Financial Officer | A | Common Stock | 18500 | $0.00 | 21,852.0000 | 0 | 551.91% | 0.00% |
| Jan. 12, 2023 | LEVIN ARTHUR A | Chief Scientific Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 78,423.0000 | 0 | 11.31% | 0.00% |
| Jan. 12, 2023 | LEVIN ARTHUR A | Chief Scientific Officer | S | Common Stock | 10000 | $22.00 | 275,202.0000 | 0 | 3.51% | 0.00% |
| Jan. 12, 2023 | LEVIN ARTHUR A | Chief Scientific Officer | M | Common Stock | 10000 | $1.24 | 285,202.0000 | 0 | 3.63% | 0.00% |
| Dec. 29, 2022 | LEVIN ARTHUR A | Chief Scientific Officer | M | Stock Option (Right to Buy) | 40000 | $0.00 | 88,423.0000 | 0 | 31.15% | 0.00% |
| Dec. 29, 2022 | LEVIN ARTHUR A | Chief Scientific Officer | S | Common Stock | 40000 | $22.01 | 1,330.0000 | 0 | 96.78% | 0.00% |
| Dec. 29, 2022 | LEVIN ARTHUR A | Chief Scientific Officer | M | Common Stock | 40000 | $1.24 | 41,330.0000 | 0 | 3007.52% | 0.00% |